Calculating and Allocating Drugs Costs
Dispensing Contractors
Financial Planning Guidance
Help With Health Costs
Hospital ePACT.net
PPD Publications
Information Services
New Contractual Framework for Community Pharmacy
Presc info/PMD Guidance
PCT Information
Pharmacy Contractor Payments
PPD Exhibitions
PPD Public Meetings
Prescription Form Product Area
Prescription Form Overprint Specifications
Prescription Forms Used by Nurse and Supplementary Prescribers
Processing and Pricing
Purchasing: Terms & Conditions
Quality
Repeat Dispensing Information
Resources
Safer Management of Controlled Drugs
Social Work Bursary
Resources
 
PPD
 

How to prevent common endorsing errors

Generic items included in Part VIII of the Drug Tariff continues to be the most significant area where unnecessary endorsements are added by contractors (see our article headed 'Information for pharmacy contractors on the sorting, submission and endorsement of prescription forms').


A common area where the PPD is unable to accept endorsements made by pharmacy contractors relates to prescriptions where the strength, number or quantity is not stated by the prescriber. General guidance on prescribing is contained in the BNF on the action pharmacists should take when an incomplete prescription for a systemically administered preparation (other than for a controlled drug) is received. The BNF guidance covers situations where the prescriber has been contacted but it has not proved possible to obtain the prescriber's written intention (p.c.) and those situations where the prescriber cannot be contacted (p.n.c.).

How should prescriptions be endorsed in these circumstances?

Strength not stated by the prescriber and :-

  • the prescription item has more than one strength
  • the strength is not stated by the prescriber
  • the pharmacist endorses that the larger strength has been dispensed
in these cases the prescription must also be endorsed by the pharmacist either p.c. or p.n.c. (and initialled and dated) without either of these endorsements, the PPD is unable to accept the larger strength as added by the pharmacist and is required to return the form.

Action needed by pharmacists: ensure that p.c or p.n.c is endorsed (and initialled and dated).

Number or quantity not stated by the prescriber

  • the number or quantity is not stated by the prescriber
  • where the prescriber is contacted, the number/quantity should be added by the pharmacist, with p.c. (and initialled and dated)
  • where the prescriber cannot be contacted, the pharmacist may supply sufficient to complete up to 5 days treatment (with the exceptions as outlined in the BNF). The number/quantity should be added by the pharmacist, with p.n.c. (and initialled and dated)
  • without either of theses endorsements, the PPD is unable to accept the number/quantity added by the pharmacist and is required to return the form.

Action needed by pharmacists: ensure that p.c. or p.n.c. is endorsed (and initialled and dated).

Situations where the use of p.c. or p.n.c. is not an acceptable endorsement

The convention of using the p.c. or p.n.c. endorsement relates to systemically administered preparations (other than controlled drugs) where the strength, number or quantity is not stated by the prescriber. An endorsement of p.c. or p.n.c. cannot be accepted by the PPD when e.g.:

  • A different presentation has been dispensed to that prescribed, for example tablets x prescribed which are available in two presentations non-modified release and modified release. The use of p.c. to supply the modified release cannot be accepted by the PPD and instead the prescriber's endorsement is needed
  • A different drug/appliance/dressing has been dispensed to the one prescribed.

Action needed by pharmacists: the prescriber's endorsement is needed in circumstances where the pharmacist dispenses a different presentation or different item to that ordered by the prescriber.

Your usual PPD contact processing division team leader or the PPD Pharmaceutical Directorate will be pleased to provide advice on the different types of endorsements that are needed. You can contact the Pharmaceutical Directorate on 0191 203 5275.


.
SearchBack to Top
   
  © NHS Business Services Authority
  Use of Personal Data - your rights, our responsibilities